| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.11.24 | Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer | 162 | GlobeNewswire (Europe) | BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of... ► Artikel lesen | |
| 09.11.24 | Fate Therapeutics, Inc.: Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual ... | 238 | GlobeNewswire (Europe) | Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable... ► Artikel lesen | |
| 09.11.24 | Replimune Group Inc: Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society ... | 163 | GlobeNewswire (Europe) | Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity across all subgroups with injected and non-injected lesions responding with similar frequency, depth, duration... ► Artikel lesen | |
| 09.11.24 | Ultragenyx Pharmaceutical Inc.: Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST's 17th Annual Global Science Summit | 159 | GlobeNewswire (Europe) | Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year... ► Artikel lesen | |
| 09.11.24 | GoldHaven Resources Corp.: GoldHaven Completes Acquisition of Copper Peak Metals Inc. | 620 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS0) announces that, further to its news release... ► Artikel lesen | |
| 09.11.24 | Nasdaq, Inc.: AppLovin Corporation to Join the Nasdaq-100 Index Beginning November 18, 2024 | 928 | GlobeNewswire (Europe) | NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that AppLovin Corporation (Nasdaq: APP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100... ► Artikel lesen | |
| 09.11.24 | Monsha'at: Monsha'at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements | 808 | GlobeNewswire (Europe) | RIYADH, Saudi Arabia, Nov. 09, 2024 (GLOBE NEWSWIRE) -- The Small and Medium Enterprises General Authority of the Kingdom of Saudi Arabia, Monsha'at, has taken another important step towards reshaping... ► Artikel lesen | |
| 09.11.24 | FUJIFILM Europe GmbH: New DeepInsight 'the next stage' by FUJIFILM | 939 | GlobeNewswire (Europe) | Explore the depths of ultrasound for early diagnosis.
RATINGEN, Germany, Nov. 09, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe is proud to launch the next stage of DeepInsight, an innovative... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 5.143 |
| STEYR MOTORS | 2.900 |
| RENK GROUP | 2.680 |
| RHEINMETALL | 2.595 |
| BYD | 2.109 |
| DEUTZ | 1.928 |
| TUI | 1.756 |
| TESLA | 1.666 |
| EVOTEC | 1.415 |
| NEL | 1.217 |
| APPLE | 1.164 |
| ASML | 1.115 |
| BASF | 983 |
| DEUTSCHE BANK | 957 |
| MERCEDES-BENZ | 943 |
| NOVO NORDISK | 925 |
| INFINEON | 917 |
| BAYER | 875 |
| PUMA | 875 |
| VOLKSWAGEN | 868 |
| THYSSENKRUPP | 866 |
| XIAOMI | 866 |
| LVMH | 858 |
| ALLIANZ | 826 |
| PLUG POWER | 815 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
